Literature DB >> 25366679

Organ-sparing multimodality treatment for muscle-invasive bladder cancer: can we continue to ignore the evidence?

Claus Rödel1, Christian Weiss2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25366679     DOI： 10.1200/JCO.2014.58.5521

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy.

Authors:  Michael A Feuerstein; Anuj Goenka
Journal:  Curr Urol Rep       Date:  2015-11       Impact factor: 3.092

2.  Radiosensitization In Vivo by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation Toxicity.

Authors:  Blaz Groselj; Jia-Ling Ruan; Helen Scott; Jessica Gorrill; Judith Nicholson; Jacqueline Kelly; Selvakumar Anbalagan; James Thompson; Michael R L Stratford; Sarah J Jevons; Ester M Hammond; Cheryl L Scudamore; Martin Kerr; Anne E Kiltie
Journal:  Mol Cancer Ther       Date:  2017-08-24       Impact factor: 6.261

3.  Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2).

Authors:  Ricarda Merten; Oliver Ott; Marlen Haderlein; Simone Bertz; Arndt Hartmann; Bernd Wullich; Bastian Keck; Reinhard Kühn; Claus Michael Rödel; Christian Weiss; Christine Gall; Wolfgang Uter; Rainer Fietkau
Journal:  Oncologist       Date:  2019-07-10

4.  Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience.

Authors:  Marianna A Gerardi; Barbara A Jereczek-Fossa; Dario Zerini; Alessia Surgo; Samantha Dicuonzo; Ruggero Spoto; Cristiana Fodor; Elena Verri; Maria Cossu Rocca; Franco Nolè; Matteo Muto; Matteo Ferro; Gennaro Musi; Danilo Bottero; Deliu V Matei; Ottavio De Cobelli; Roberto Orecchia
Journal:  Ecancermedicalscience       Date:  2016-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.